Oncology Peer Review On-The-Go: Fertility Preservation Decision-Making for Adolescents with Cancer

Podcast

The latest episode of the journal ONCOLOGY’s podcast features an article published in the November issue discussing fertility preservation and decision-making for young adults with cancer.

This episode of "Oncology Peer Review On-The-Go" looks at an article published in the November issue of the journal ONCOLOGY, titled “Supporting Decision-Making on Fertility Preservation Among Adolescent and Young Adult Women With Cancer.” The piece examines oncofertility, unexpected cancer diagnoses and the decision-making process for young adult patients. For a breakdown of the article, CancerNetwork spoke with co-author of the review article, Jackelyn Payne, MPH, MA, a doctoral student in the department of psychology at Stony Brook University.

For the response perspective, CancerNetwork spoke with Elizabeth Constance, MD, who is an associate professor at the University of Nebraska Medical Center. Constance wrote a perspective piece published in the journal ONCOLOGY titled “Opening Doors: Fertility Preservation for Adolescents and Young Adults Facing Gonadotoxic Therapy.” The piece highlights the evolving decision-making process for patients, the potential for multi-disciplinary treatment teams and more.

To read the full article, visit cancernetwork.com.

Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast on Apple Podcasts, Spotify or anywhere podcasts are available.

Related Videos
Amrita Y. Krishnan, MD, and Binod Dhakal, MD
Amrita Y. Krishnan, MD, and Binod Dhakal, MD
Advocacy groups such as Cancer Support Community and the Leukemia & Lymphoma Society may help support patients with CML undergoing treatment.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.
A panel of 4 experts on multiple myeloma
Data from the REVEAL study affirm elevated white blood cell counts and higher variant allele frequency as risk factors for progression in polycythemia vera.
Video 1 - 4 KOLs are featured in "Triaging and Prioritizing Patients with Multiple Myeloma"
Video 1 - 4 KOLs are featured in "CAR T-Cell Therapy: Leukapheresis Practices"
A panel of 4 experts on multiple myeloma
Related Content